This book highlights and discusses the advances in developing pharmaceutical amorphous solid dispersions. Chapters, written by contributing authors on the frontlines of R & D, provide a roadmap from early to late stages of drug development. They cover topics that include: physical and chemical properties, screening, scale-up, formulation, drug product manufacture, intellectual property, and regulatory considerations. A concluding appendix monograph provides important drug development information on commonly used polymers such as structure, grades, molecular weight range, glass transition temperature or melting temperature, solubility parameter, and water uptake.